Skip to main content
Equibles

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1164508 BOSTON, MA
Back to NTLA Full portfolio

Position in NTLA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$55,510,459
+$37,597,804 QoQ
Shares Held
3,280,760
+134.8% QoQ
Ownership
2.34%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#12
of 330 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $2,515,799,583 across 71 Biotechnology names. NTLA ranks #9 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 738,378 $366,774,503
2 INCY
Incyte Corp
 2,744,958 $311,168,438
3 REGN
Regeneron Pharmaceuticals, Inc.
 393,685 $245,478,344
4 EXEL
Exelixis, Inc.
 4,365,926 $237,550,033
5 GMAB
Genmab A/S
 4,975,324 $136,672,150
6 RPRX
Royalty Pharma plc
 2,435,341 $136,549,569
7 HALO
Halozyme Therapeutics, Inc.
 1,704,623 $133,420,842
8 ONC
BeOne Medicines Ltd.
 249,758 $71,173,537

All Filings in NTLA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $55,510,459 3,280,760
2026-03-31 $17,912,655 1,397,243